Smith et al. [34] previously reported this phenomenon as the flare effect following intralesional immunotherapy with activated lymphocytes and IL-2, in patients with recurrent high grade astrocytomas [34]. The gene discussed is IL2; the disease is high grade astrocytic tumor.